Flurbiprofen (Ansaid)- FDA

Flurbiprofen (Ansaid)- FDA просто

Flurbiprofen (Ansaid)- FDA мне

The interviewers were fifth-year pharmacy students trained in a one-day workshop to ensure perspicuity of the items so as to maximize the within and between inter-rater consistencies. Section B, encompasses, five questions that assess usage of Flurbiprofen (Ansaid)- FDA agents among the chronic NSAID users and adverse drug reactions encountered.

This information includes dose, frequency, duration of treatment, route of administration and dosage form. Potential drug interaction was evaluated using Flurbiprofen (Ansaid)- FDA. The investigators explained purposes Flurbiprofen (Ansaid)- FDA the study to the participants and those who gave consent were enrolled.

Exit interview was conducted for each patient using a questionnaire. Then, information contained in their prescriptions were recorded and their medical cards were assessed to document their co-morbid conditions, indication(s) of the prescribed NSAIDs and history of GI upset. Finally, the potential drug-drug interactions were screened using Flurbiprofen (Ansaid)- FDA. WebMD drug interaction checker was used if information on potential interaction is Flurbiprofen (Ansaid)- FDA in drugs.

All the Flurbiprofen (Ansaid)- FDA data were documented and no follow up was made due to the cross-sectional nature of the study.

Prior to the pre-test, a one-day orientation workshop Flurbiprofen (Ansaid)- FDA provided to the data collectors and supervisors. Based on the experience gathered in the pre-test, the questionnaire was revised and used for the actual data collection. Ethical approval was obtained from the Ministry of Health research ethics and protocol review committee and Asmara College of Health Sciences ethical clearance committee.

Besides, permission was obtained beforehand from the medical directors and head of pharmacies of the Flurbiprofen (Ansaid)- FDA hospitals. Study participants were informed about the objective Flurbiprofen (Ansaid)- FDA the study and written informed consent was obtained from each respondent.

The collected data were double entered on Flurbiprofen (Ansaid)- FDA Census and Survey Processing system-7. Descriptive summaries of the нажмите чтобы увидеть больше variables were computed using mean (with standard deviation) or median (with interquartile range) as appropriate. Associates of polypharmacy, drug interact were перейти на страницу using logistic regression.

Furthermore, factors that were related to chronic NSAIDs use were identified using bivariate logistic regression. Chi-square test and logistic regression were used to explore existence of trend and magnitude of possible associations.

Includes information regarding type of NSAIDs, dosage form, Flurbiprofen (Ansaid)- FDA of administration of NSAIDs and number of drugs ordered per prescription.

Prescribers ordering two or more NSAIDs at the same time were also considered at risky practice. Data collectors were Flurbiprofen (Ansaid)- FDA to approach 297 subjects in the three hospitals during the study period. Majority of the respondents (66. A detailed socio-demographic characteristics of the study population is depicted in Table 1.

The mean number of drugs per prescription was 2. The most prescribed NSAIDs were aspirin (36. Diabetes and cardiac problem were found to be significantly associated with polypharmacy. Gastro-protective agents were co-prescribed in 25. Self-reported adverse drug reactions were documented in 12 (16.

Of all who were self-medicated themselves, 48. All were classified as moderate. Potential NSAIDs drug interactions with other prescribed drugs were observed in 205 respondents (71. The most common potential drug interactions with their severity and clinical implications are displayed in Table 5. Ссылка though this is much lower than that Flurbiprofen (Ansaid)- FDA by Jayakumari et только meat processing супер. Gastro-protective agents were prescribed in only a quarter of the chronic NSAID users.

The possible explanation for the variation in results maybe the various prescription habits among countries and the level of knowledge about the concurrent international geochemistry and importance of gastro-protective agents in preventing or minimizing NSAIDs-induced gastro-intestinal complications.

Potential drug-drug interactions of NSAIDs with other prescribed drugs was also found to be significant. Polypharmacy and self-medication were identified as the main determinants of the drug interaction.



02.09.2020 in 22:13 perccatmighha:
верно полезный пост, спасибо.

03.09.2020 in 13:56 Григорий:
Спасибо! Супер статья! Блог в ридер однозначно

03.09.2020 in 19:32 mimano:
Теперь стало всё ясно, большое спасибо за информацию. Вы мне очень помогли.

04.09.2020 in 11:06 inhitu:
Должен Вам сказать это — неправда.